Literature DB >> 28579972

Editorial: Vestibular Migraine.

Mark Obermann1.   

Abstract

Entities:  

Keywords:  dizziness; headache; neuro-otology; vertigo; vestibular migraine

Year:  2017        PMID: 28579972      PMCID: PMC5437103          DOI: 10.3389/fneur.2017.00213

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


× No keyword cloud information.
Editorial on the Research Topic Vestibular migraine (VM) is now the accepted name for vestibular symptoms that are causally related to migraine. The International Headache Society and the International Bárány Society for Neurootology together have developed a consensus document with diagnostic criteria for VM (1), but the existence and the relation to migraine is still disputed by some clinicians and researchers alike. Our research topic VM tried to shed more light on the clinical features as well as pathophysiological origin of this interesting and unique disorder. Different aspects of this disorder were highlighted and included genetics, pathophysiology, clinical phenotype in adults and children, diagnostic findings, as well as treatment options. There are solid indications that VM shares at least some pathophysiological features with migraine, but also entails some unique features that separate it from migraine with or without aura and underline its claim as specific disease entity. For those that acknowledge the existence, VM is considered the most common cause of recurrent spontaneous vertigo attacks. It has a lifetime prevalence of about 1% and a one-year prevalence of 0.9% in the general population (2) and accounts for about 7% of patients seen in dizziness clinics and 9% of patients seen in migraine clinics (3). Nevertheless, it is still underdiagnosed and not well understood. It has been proposed that VM has a genetic cause, namely an autosomal dominant pattern of inheritance with decreased penetrance in men (4), but a lot of research is needed to further clarify its underlying pathophysiology and the relation to migraine in this regard. Clinical studies on specific diagnostic clues and therapeutic agents specific for the treatment of VM only just started and will have to be intensified in the future.

Author Contributions

The author confirms being the sole contributor of this work and approved it for publication.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  4 in total

1.  Epidemiology of vestibular vertigo: a neurotologic survey of the general population.

Authors:  H K Neuhauser; M von Brevern; A Radtke; F Lezius; M Feldmann; T Ziese; T Lempert
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

2.  Vestibular migraine: diagnostic criteria.

Authors:  Thomas Lempert; Jes Olesen; Joseph Furman; John Waterston; Barry Seemungal; John Carey; Alexander Bisdorff; Maurizio Versino; Stefan Evers; David Newman-Toker
Journal:  J Vestib Res       Date:  2012       Impact factor: 2.435

3.  Familial clustering of migraine, episodic vertigo, and Ménière's disease.

Authors:  Yoon-Hee Cha; Michael J Kane; Robert W Baloh
Journal:  Otol Neurotol       Date:  2008-01       Impact factor: 2.311

4.  Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine.

Authors:  Vlasta Vuković; Davor Plavec; Ivana Galinović; Arijana Lovrencić-Huzjan; Mislav Budisić; Vida Demarin
Journal:  Headache       Date:  2007 Nov-Dec       Impact factor: 5.887

  4 in total
  1 in total

1.  Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).

Authors:  Otmar Bayer; Christine Adrion; Amani Al Tawil; Ulrich Mansmann; Michael Strupp
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.